Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2004–2027 · research · R37
Genetic analysis of innate immunity using C. elegans
Alejandro Aballay · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2004–2021 · research · R01
Regulation of Lung Cancer Metastasis by a Procollagen Lysine Hydroxylase
Jonathan M Kurie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2004–2020 · research · R01
Molecular Mechanisms Regulating TLR Signaling and Macrophage Activation.
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2004–2020 · research · R01
Molecular Mechanisms Regulating TLR Signaling and Macrophage Activation.
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2004–2020 · research · R01
Regulation of Lung Cancer Metastasis by a Procollagen Lysine Hydroxylase
Jonathan M Kurie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2004–2020 · research · R01
Molecular Mechanisms Regulating TLR Signaling and Macrophage Activation.
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2022 · research · R01
Molecular Studies of Noncanonical NF-kb Signaling
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2023 · program · P50
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
Marina Y Konopleva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2021 · training · T32
Training of Academic Gynecologic Oncologists
Karen Hsieh Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2021 · program · P50
MD Anderson Gynecologic SPORE for Uterine Cancers
Russell R Broaddus · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2021 · program · P50
Revision: MD Anderson Gynecologic SPORE for Uterine Cancers
Russell R Broaddus · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2023 · program · P50
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
Jean-Pierre J. Issa · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2021 · program · P50
MD Anderson Gynecologic SPORE for Uterine Cancers
Russell R Broaddus · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2022 · research · R01
Molecular Studies of Noncanonical NF-kb Signaling
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2022 · program · P50
MD Anderson Gynecologic SPORE for Uterine Cancers
Russell R Broaddus · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2022 · research · R01
Molecular Studies of Noncanonical NF-kb Signaling
Shao-Cong Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2023 · program · P50
P2: CTNNB1 Mutation and Wnt Pathway Activation Define Clinically Aggressive Endometrioid Endometrial Carcinoma
Russell R Broaddus · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2023 · program · P50
Administrative Core
Karen Hsieh Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2024 · program · P50
Developmental Research Program
William K Plunkett · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2023 · program · P50
Developmental Research Program
Russell R Broaddus · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2024 · program · P50
Core 3: Biostatistics, Data Management, and Bioinformatics
Xuelin Huang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2024 · program · P50
Project 2: Anti-PR1 Immune Therapy for Myeloid Leukemia
Jeffrey J Molldrem · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2024 · program · P50
Career Enhancement Program
Marina Y Konopleva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2024 · program · P50
Core 2: Pathology and Tissue Core
Steven M Kornblau · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2024 · program · P50
Administrative Core
Marina Y Konopleva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2021 · program · P50
Biomarkers Core
David S Loose · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2023 · program · P50
P1: Novel Targeted Strategies for Prevention and Conservative Management of Complex Atypical Hyperplasia and Grade 1 Endometrioid Endometrial Cancer
Karen Hsieh Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2003–2023 · program · P50
P3: EphA2 Targeting in Uterine Carcinoma
Anil K Sood · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2024 · cooperative agreement · U54
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
Sharon Hermes Giordano · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2022 · research · R01
The Functional Analysis of the Coactivator CARM1
Mark T. Bedford · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2024 · cooperative agreement · U54
UPR/MDACC Partnership for Excellence in Cancer Research (Luis Segarra supplement)
Michelle Ann Barton · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2025 · cooperative agreement · U54
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
Sharon Hermes Giordano · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2024 · cooperative agreement · U54
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
Michelle Ann Barton · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2023 · research · R01
The Functional Analysis of the Coactivator CARM1
Mark T. Bedford · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2024 · cooperative agreement · U54
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
Sharon Hermes Giordano · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2022 · research · R01
The Functional Analysis of the Coactivator CARM1
Mark T. Bedford · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2024 · cooperative agreement · U54
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
Sharon Hermes Giordano · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2024 · cooperative agreement · U54
Administrative Core
Elizabeth L Travis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2024 · cooperative agreement · U54
Pilot Project 1: Combination of Viroimmunotherapy and Microbiota Modulation to Treat Gastric Cancer
Candelaria Gomez-Manzano · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2002–2024 · cooperative agreement · U54
Planning and Evaluation Core (PEC)
Cullen Mitsuo Taniguchi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
